Roche Kapa HyperCap Design Share Non-Hodgkin Lymphoma Panel

Roche has launched its Kapa HyperCap Design Share Non-Hodgkin Lymphoma Panel to allow researchers to detect and perform longitudinal analyses on cell-free circulating tumor DNA. It covers single nucleotide variants in coding and untranslated regions of 383 genes, plus additional intergenic regions for a total capture size of 341 kb. These regions are enriched in genomic alterations associated with non-Hodgkin lymphoma. The panel is available for research use only.